These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 25187755

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM, Duch P, Allingstrup M, Afshari A.
    Cochrane Database Syst Rev; 2017 Aug 14; 8(8):CD012763. PubMed ID: 28806470
    [Abstract] [Full Text] [Related]

  • 3. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May 14; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ, Woo T, Assaid CA, Lupinacci RJ, Lemmens HJ, Blobner M, Khuenl-Brady KS.
    J Clin Anesth; 2017 Sep 14; 41():84-91. PubMed ID: 28802619
    [Abstract] [Full Text] [Related]

  • 6. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
    Aouad MT, Alfahel WS, Kaddoum RN, Siddik-Sayyid SM.
    BMC Anesthesiol; 2017 Apr 11; 17(1):57. PubMed ID: 28399799
    [Abstract] [Full Text] [Related]

  • 7. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 8. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B, Sasaki N, Grobara P, Li MK, Woo T, de Bie J, Maktabi M, Lee J, Kwo J, Pino R, Sabouri AS, McGovern F, Staehr-Rye AK, Eikermann M.
    Br J Anaesth; 2015 Nov 01; 115(5):743-51. PubMed ID: 25935840
    [Abstract] [Full Text] [Related]

  • 9. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar 01; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M, Zarantonello F, Tellaroli P, Ori C.
    J Clin Anesth; 2016 Dec 01; 35():1-12. PubMed ID: 27871504
    [Abstract] [Full Text] [Related]

  • 11. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G, Niskanen M, Laurila P, Mizikov V, Hübler M, Beck G, Rietbergen H, Nicolayenko E.
    Anaesthesia; 2012 Sep 01; 67(9):991-8. PubMed ID: 22698066
    [Abstract] [Full Text] [Related]

  • 12. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N, Berger C, Wittmann M, Solomon C, Abels EA, Rietbergen H, Reuter DA.
    Anaesthesist; 2015 Jul 01; 64(7):506-12. PubMed ID: 26126940
    [Abstract] [Full Text] [Related]

  • 13. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS, Mahmoud KM, Kasemy ZA.
    Acta Anaesthesiol Scand; 2017 Apr 01; 61(4):374-380. PubMed ID: 28185260
    [Abstract] [Full Text] [Related]

  • 14. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug 01; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 15. Sugammadex is effective in reversing rocuronium in the presence of antibiotics.
    Hudson ME, Rietbergen H, Chelly JE.
    BMC Anesthesiol; 2014 Aug 01; 14():69. PubMed ID: 25157214
    [Abstract] [Full Text] [Related]

  • 16. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.
    Woo T, Kim KS, Shim YH, Kim MK, Yoon SM, Lim YJ, Yang HS, Phiri P, Chon JY.
    Korean J Anesthesiol; 2013 Dec 01; 65(6):501-7. PubMed ID: 24427455
    [Abstract] [Full Text] [Related]

  • 17. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I.
    Anesthesiology; 2007 Feb 01; 106(2):283-8. PubMed ID: 17264722
    [Abstract] [Full Text] [Related]

  • 18. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
    Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM.
    Br J Anaesth; 2008 Oct 01; 101(4):492-7. PubMed ID: 18653492
    [Abstract] [Full Text] [Related]

  • 19. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007362. PubMed ID: 19821409
    [Abstract] [Full Text] [Related]

  • 20. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA, Bornemann H, Hopfgartner E, Ohran M, Kocher K, Liebmann M, Wilfinger G, Metzler H.
    Br J Anaesth; 2012 Apr 07; 108(4):602-6. PubMed ID: 22315331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.